This company listing is no longer active
Genocea Biosciences Dirección
Dirección controles de criterios 2/4
Información clave
Chip Clark
Chief Executive Officer (CEO)
US$3.8m
Compensación total
| Porcentaje del salario del CEO | 15.2% |
| Permanencia del CEO | 11.6yrs |
| Participación del CEO | 0.05% |
| Permanencia media de la dirección | 6.6yrs |
| Promedio de permanencia en la Junta Directiva | 8yrs |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2022 | n/a | n/a | -US$37m |
| Dec 31 2021 | US$4m | US$571k | -US$33m |
| Sep 30 2021 | n/a | n/a | -US$35m |
| Jun 30 2021 | n/a | n/a | -US$36m |
| Mar 31 2021 | n/a | n/a | -US$43m |
| Dec 31 2020 | US$1m | US$551k | -US$44m |
| Sep 30 2020 | n/a | n/a | -US$38m |
| Jun 30 2020 | n/a | n/a | -US$41m |
| Mar 31 2020 | n/a | n/a | -US$36m |
| Dec 31 2019 | US$1m | US$533k | -US$39m |
| Sep 30 2019 | n/a | n/a | -US$29m |
| Jun 30 2019 | n/a | n/a | -US$30m |
| Mar 31 2019 | n/a | n/a | -US$27m |
| Dec 31 2018 | US$1m | US$515k | -US$28m |
| Sep 30 2018 | n/a | n/a | -US$39m |
| Jun 30 2018 | n/a | n/a | -US$48m |
| Mar 31 2018 | n/a | n/a | -US$59m |
| Dec 31 2017 | US$2m | US$493k | -US$57m |
| Sep 30 2017 | n/a | n/a | -US$62m |
| Jun 30 2017 | n/a | n/a | -US$58m |
| Mar 31 2017 | n/a | n/a | -US$54m |
| Dec 31 2016 | US$1m | US$455k | -US$50m |
| Sep 30 2016 | n/a | n/a | -US$44m |
| Jun 30 2016 | n/a | n/a | -US$41m |
| Mar 31 2016 | n/a | n/a | -US$40m |
| Dec 31 2015 | US$2m | US$427k | -US$42m |
Compensación vs. Mercado: La compensación total de Chip($USD3.75M) está por encima de la media de empresas de tamaño similar en el mercado German ($USD471.14K).
Compensación vs. Ingresos: La compensación de Chip ha aumentado mientras la empresa no es rentable.
CEO
Chip Clark (53 yo)
11.6yrs
Permanencia
US$3,750,857
Compensación
Mr. William D. Clark, M.B.A., also known as Chip, has been an Independent Director at iBio, Inc. since August 26, 2021. He has been the Director, Chief Executive Officer and President at Genocea Bioscience...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 11.6yrs | US$3.75m | 0.048% € 314.6 | |
| Chief Scientific Officer | 6.6yrs | US$1.27m | 0.00087% € 5.7 | |
| CFO & Secretary | 3.5yrs | sin datos | 0.00051% € 3.3 |
6.6yrs
Permanencia media
50yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de GBI1 es experimentado (6.6 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 11.6yrs | US$3.75m | 0.048% € 314.6 | |
| Independent Chairman of the Board | 8yrs | US$120.98k | 0% € 0 | |
| Independent Director | 7.6yrs | US$78.48k | 0% € 0 | |
| Independent Director | 9.5yrs | US$75.88k | 0.0066% € 43.3 | |
| Independent Chairman of Scientific Advisory Board & Director | 15.7yrs | US$66.98k | 0.00043% € 2.8 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | less than a year | US$61.50k | 0% € 0 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | less than a year | sin datos | 0% € 0 |
8.0yrs
Permanencia media
53.5yo
Promedio de edad
Junta con experiencia: La junta directiva de GBI1 se considera experimentada (8 años de antigüedad promedio).